Before reading this, please understand that I have derived these numbers as a ”potential valuation” of what CYCA could mature into existence through the logical deduction I have explained below. It is not fact. It is only speculative in nature and should be used only as a tool to help one deduce the growth of CYCA as more is released through its PRs and SEC filings.
Before I explain where CYCA could potentially be trading and why, I think there are a few things that need to be made clear for investors to understand the full magnitude of what we have here in CYCA.
From an earlier CYCA PR, read below to understand this key connection: http://finance.yahoo.com/news/Cytta-Appoints-Exceptional-iw-2198779498. …Mr. Harz with his wife Marilyn K. Harz RN, Ph.D. continue to work together in the development of medical products to better manage the healthcare needs of people with chronic conditions in preparation for healthcare reform. …
Now, in getting back to discussing the over 600,000 patients that are there under Heritage, it brings the potential below given a $50 per month cost for utilizing the service that is to be used by CYCA for those patients if a deal is struck…
600,000 x $50 = $30,000,000 per month
$30,000,000 per month x 12 months = $360,000,000
As you can see, this is just from one company, the Heritage Provider Network, Inc. Let’s go conservative and presume that if such a deal was to take place, they would only get 60,000 instead of 600,000 of the patients within Heritage. This would make for $3,000,000 per month with an annual total of $36,000,000 per year. Still, $36,000,000 is a very solid amount considering this potentially being just one deal from one facility.
Even with its newly known OS of 1,014,616,666 shares, we can derive the EPS below:
$36,000,000 x .25 = $9,000,000
$9,000,000,000 ÷ 1,014,616,666 = .0088 per share
Multiply now the .0088 by a conservative PE Ratio of 12 to derive below…
.0088 x 12 = .1056 per share
Please understand, this is not me saying that CYCA is definitely going to hit .1056 per share, but I am saying that it is worth taking the risk at these levels in my opinion.
Lifespan has licensed Cytta Corp. (now CYCA) the exclusive right to utilize Lifespan’s ‘ScreenPhone’ technology to develop, manufacture and market telephone/internet access devices for the US.
IMPORTANT READ: ScreenPhone was formed in 1998 and partnered with Iphone (later acquired by Cisco) Mitsui, Sanyo and ultimately Samsung on thehardware and software development of an Internet capable telephone device called the AnyWeb/ScreenPhone. This development took five years from 1998 to 2003 and over $70 million dollars. The primary market for this product was to be US healthcare and to that end ScreenMD was formed to do all the development work, promotion and sales. Numerous major players had also decided to implement th is technology (Aetna, WebMD, UPMC).
This project was acquired by Lifespan in 2003, but due to a corporate restructure during a time of market irregularities the ScreenPhone/Anyweb was never delivered in quantity by Samsung forcing Lifespan to put the project on hold until a suitable technology was available to implement the software, operating systems and models. Until very recently the appropriate Internet access technology (smartphones) was not available and until now there was not the government will to implement this system. This has now all changed with the mandate given to the medical market to implement exactly the technology and systems which Lifespan developed. Even more exciting is that GE, Intel, Phillips, Google, Microsoft and numerous other players are now entering and recognizing the market at which Lifespan should be able to excel.
Lifespan says it has been approached by a major partner wishing to assist in the implementation of the home based medical testing systems and electronic medical record (EMR) technology previously acquired by the Company and currently described as the ‘Advanced Medical division’.
The primary benefits of the Lifespan’s model are clinical, resulting in superior patient outcomes, psychosocial, resulting in better patient satisfaction, and economic, resulting in significantly lower costs. The Advanced Medical technology and system is focused upon connecting leading edge home based medical diagnostic and testing equipment securely through any wireless device to the client’s Electronic Medical Record portal. http://www.themobilehealthcrowd.com/?q=node/188 http://www.otcmarkets.com
The importance of the Healthcare Reform Bill just signed by President Obama making it a law could have a significant impact here with CYCA moving forward with the executing of their business objectives in a few different ways. The one thing that all investors should consider is the recently released PR by CYCA below…
Cytta Appoints Exceptional Vice President and Director to Coordinate Medical Project
(from the CYCA PR above)… The Advanced Medical system is focused upon connecting leading edge home based medical diagnostic and testing equipment securely through any wireless device to the client's Electronic Medical Record portal. …
Importantly, to add, because CYCA will now be venturing off into the EMR world, CYCA will be in line for some huge funding support because the 111th Congress of the United States had granted to be mandated, through the American Recovery and Reinvestment Act of 2009, that all medical records must be electronically stored and save by the year 2014 or providers not in compliance will be faced with penalties.
[-chart]investorshub.advfn.com/uimage/uploads/2010/4/1/vwoqkCYCA_Medical_Apps_Slide.jpg[-/chart] =========================================================== CYCA Share Structure; As of February 10, 2010 per 10Q filed with the SEC:
Lifespan Inc. 120,000,000 Common Shares 19.8% of O/S Lando Technologies, Inc. 96,000,000 Common Shares 15.9% of O/S Lincoln Financial Group, Inc. 40,000,000 Common Shares 6.6% of O/S ========================================================= ** Insiders own 42.3% of the OS. ========================================================== PINKSHEETS: http://www.otcmarkets.com/pink/quote/quote.jsp?symbol=cyca [-chart]www.otcmarkets.com/content/doc/ps/tier/logo/10.gif[-/chart]
Contact Information - Business Description Cytta Corp. 905 Ventura Way Mill Valley, CA 94941 Phone: 415-860-5192
OTC Market Tier OTCQB; Primary SIC — Industry Classification 7389 - Business services, misc State Of Incorporation NV Jurisdiction Of Incorporation; United States Year Of Incorporation 2006
Company Officers;Stephen Spalding, CEO, Dir.Gary Campbell, President, Secretary, Dir.
Estimated Market Cap $1,521,220 as of May 27, 2010 Outstanding Shares 661,400,000 as of Aug 13, 2009
Current Capital Change shs increased by 20 for 1 split, payable upon surrender. Pay Date: Aug 11, 2009 Security Notes ?Capital Change=shs increased by 4 for 1 split, payable upon surrender. Pay date=12/04/2008.
Transfer Agent Island Stock Transfer 100 Second Avenue South Suite 705S St. Petersburg, FL 33701
CYCA CYTTA CORP Analysis of CYCA, CYTTA CORP in American and Canadian Stock Markets NYSE, NASDAQ, AMEX, OTC, TSX,and CDNX, End-of-Day Stock Data, Alert Signals Buy, ... americanbulls.com/StockPage.asp?CompanyTicker=CYCA&...&Typ=S
CYCA Cytta - Penny Stock Exposed Cytta - Detailed financial news for CYCA. Cytta Corp., a development stage company, focuses on developing a Web-based advertising service for the contractors in Canada. ... www.realpennies.com/otc/CYCA
Cytta Corp: OTC:CYCA quotes & news - Google FinanceGet detailed financial information on Cytta Corp (OTC:CYCA) including real-time stock quotes, historical charts & financial news, all for free! www.google.com/finance?q=OTC:CYCA
Promotion Pitching Cytta Corp (OTC:CYCA) Stock Beyond LimitsMar 25, 2010 ... Yesterday, an unparalleled movement of Cytta Corp (OTC:CYCA) stock allowed investors to see fat gains. CYCA's shares rose 0.0027 cents, ... www.hotstocked.com/.../
DISCLAIMER - Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have positions in the stocks discussed and may trade in the stocks mentioned. Readers are advised to conduct their own due diligence prior to considering buying or selling any stock. All information should be considered for information purposes only.
Market Data 
Markets 
AI
